Authors of HHS report criticize recent STAT op-ed on gender-affirming care for minors for using “scare tactics.” ...
As a scientist, I am disgusted. As an NFL widow who witnessed unimaginable suffering, I am furious,” writes Eleanor M.
Hims & Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.
WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world for 43 ...
In a small trial, Roivant's immune drug significantly outperformed placebo in clearing lesions caused by a rare skin disease.
In Denmark, pediatrician Michael Thwing once saw nearly 20 infants admitted simultaneously with rotavirus. His experience in ...
China criticized the United States for withdrawing from the WHO, saying countries should not place domestic politics ahead of ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Doctors are not a flock of free-range chickens wandering about offices and hospitals and making up best practices, one ...
The Trump administration is moving forward with a personnel rule that critics say will subject a broader swath of the federal workforce to political pressure ...
ARPA-H, the “moonshot” biomedical agency established under the Biden administration, laid off staff last week, according to ...
A STAT analysis found more than 40 hospitals have paused or ceased to offer some gender-affirming care to young people since President Trump took office.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results